Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD) (PROTECT-ICD)

revascularisation (PCI or CABG). ICD implantation after 40 days according to current guidelines (LVEF≤30%, or ≤35% with New York Heart Association (NYHA) class II/III symptoms) could be considered, if part of local

  • 267 views
  • 15 May, 2022
  • 26 locations
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke (DISTAL)

Acute ischemic stroke (AIS) is one of the main causes of disability and loss of quality adjusted life years. This study is to analyze whether endovascular therapy (EVT) in addition to best medical treatment (BMT) reduces the degree of disability and dependency in daily activities after a Medium Vessel Occlusion …

  • 0 views
  • 14 Mar, 2022
  • 2 locations
Diagnostic Value of Compression Ultrasound to Detect Acute Compartment Syndrome After Lower Limb Revascularisation

been proven to correlate with invasive intra compartmental pressure (ICP) measurements. This study aims to determine CU's added diagnostic value compared to ICP in detecting ACS after revascularisation

  • 0 views
  • 23 Apr, 2022
  • 1 location
Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System

The trial will be conducted to evaluate the safety and efficacy of the BeGraft Peripheral Stent Graft System in interventional revascularisation for subjects with primary iliac artery stenosis

  • 0 views
  • 23 Jan, 2021
  • 12 locations
Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

This is a randomized, open label, cohort study, in which a total of 100 patients will be enrolled and randomly assigned to receive bivalirudin or heparin in a 1:1 ratio during short-term intervention of non-infarction related artery for acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention. NACE, MACE, …

  • 0 views
  • 09 May, 2022
  • 1 location
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO (ISCHEMIA-CTO)

Study design Prospective randomized open labeled multicenter study Hypotheses In asymptomatic patients with ≥ 10% of myocardial ischemia: PCI (Percutaneous Coronary Intervention) with latest generation of drug eluting stents is superior to optimal medical therapy in terms of relative reduction in MACCE (Major Adverse Cardiovascular and Cerebrovascular events). In symptomatic …

coronary disease
infarct
heart failure
ischemia
stroke
  • 56 views
  • 22 Mar, 2022
  • 15 locations
Total Arterial Revascularization (TAR)

Total arterial revascularisation with in-situ confihuration of BITA is superior than y-graft in patients underwent CABG.

bypass graft
arterial disease
stable angina
revascularisation
atherosclerosis
  • 14 views
  • 01 Feb, 2022
  • 1 location
Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

that at 12-month follow-up, DCB was non-inferior to DES (MACE [cardiac death, non-fatal myocardial infarction, and target-vessel revascularisation] rates: 8% vs. 9%). Although some small-scale

sirolimus
dapt
infarct
revascularisation
coronary angioplasty
  • 0 views
  • 30 Jun, 2021
  • 1 location
Very Early Versus Delayed Angiography +/- Intervention on Outcomes in Patients With NSTEMI (RapidNSTEMI)

Prospective, open, multicentre, randomised controlled trial in patients with higher risk non-ST elevation myocardial infarction acute coronary syndrome

  • 2 views
  • 26 Feb, 2022
  • 1 location
The British Heart Foundation SENIOR-RITA Trial (SENIOR-RITA)

SENIOR-RITA is a multicentre prospective open-label trial randomizing patients presenting with type 1 NSTEMI aged ≥75 years between invasive and conservative treatment strategies, to compare time from randomisation to cardiovascular death or non-fatal MI

angiography
coronary revascularization
medical therapy
stemi
  • 311 views
  • 12 Apr, 2022
  • 31 locations